Huma is on a journey to use data to deliver good health for all. By partnering with science, technology, and healthcare professionals we use these insights to transform care for people everywhere. In January 2023, Huma acquired Alcedis, a market-leader for data driven clinical research and technology. Through the acquisition, Huma will form an advanced clinical trials division offering digital solutions across the entire development pipeline, from early stage through to Phase IV hybrid and fully decentralized trials.